Description
For: The management of ejection fraction-reduced symptomatic chronic heart failure (NYHA Class II–IV). administration in place of an ACE inhibitor or other ARB, in combination with other heart failure treatments.

₨49.68
For: The management of ejection fraction-reduced symptomatic chronic heart failure (NYHA Class II–IV). administration in place of an ACE inhibitor or other ARB, in combination with other heart failure treatments.




Reviews
There are no reviews yet.